Skip to content

Current ratio at other companies

Merck & Co. logo
Merck & Co.MRK
1.3×-0.1×
Zoetis logo
ZoetisZTS
3.2×+1.4×
Elanco Animal Health Inc. logo
Elanco Animal Health Inc.ELAN
2.2×-0.6×
Neogen logo
NeogenNEOG
3.9×0.0×
Balchem logo
BalchemBCPC
2.5×+0.1×
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
2.1×-1.1×

Other financials

Income statement

See full
Revenue$383.5M+10.3%
Gross profit$125.7M+20.2%
Operating income$44.7M+33.2%
Net income$24.0M+15.1%
EPS (diluted)$0.59+15.7%

Balance sheet

See full
Cash & equivalents$54.9M-9.0%
Total debt$32.3M+27.8%
Total equity$361.8M+36.0%
Total assets$1.4B+9.7%

Cash flow

See full
Operating cash flow$16.2M-62.4%
CapEx$15.3M+97.7%
Free cash flow$890.0K-97.5%

Valuation

See full
Market cap$1.27B+31.4%
Enterprise value$1.25B+33.9%
P/E13.4×-17.1×
P/S0.9×0.0×

Profitability

See full
Gross margin32.5%+0.9pp
Operating margin12%+4.0pp
Net margin6.3%+3.7pp
FCF margin0.9%-3.3pp

Returns & leverage

See full
Return on equity30.3%+18.5pp
Debt / equity0.1×0.0×

Where this comes from

Calculated from Phibro Animal Health’s reported figures.

Based on the most recent quarter.

The official record: Phibro Animal Health’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Phibro Animal Health's current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Phibro Animal Health's current ratio?
Phibro Animal Health (PAHC) reported current ratio of 3.2× in Q1 2026.
How has Phibro Animal Health's current ratio changed year-over-year?
Phibro Animal Health's current ratio increased by 8.9% year-over-year, from 2.9× to 3.2×.
What is the long-term trend for Phibro Animal Health's current ratio?
Over 4 years (2021 to 2025), Phibro Animal Health's current ratio has grown at a -2.4% compound annual growth rate (CAGR), from 3× to 2.8×.
What does current ratio mean?
Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.